Sonoma Pharmaceuticals (SNOA) Assets Average (2011 - 2026)

Sonoma Pharmaceuticals' Assets Average history runs 16 years deep, the most recent figure standing at $13.8 million for Q1 2026.

• On a quarterly basis, Assets Average rose 0.81% year-over-year to $13.8 million in Q1 2026; TTM through Mar 2026 was $13.8 million, a 0.81% increase from a year earlier, with the FY2026 full-year figure at $13.8 million, down 2.74% from the prior year.
• Assets Average steadied at $13.8 million in Q1 2026 per SNOA's latest filing, from $13.7 million in the prior quarter.
• Across five years, Assets Average topped out at $19.1 million in Q1 2022 and bottomed at $13.7 million in Q4 2024.
• The 5-year median for Assets Average is $14.2 million (2025), against an average of $14.9 million.
• Biggest YoY gain for Assets Average was 23.69% in 2022; the steepest drop was 26.25% in 2022.
• Year by year, Assets Average stood at $14.4 million in 2022, then retreated by 2.2% to $14.1 million in 2023, then decreased by 3.19% to $13.7 million in 2024, then gained by 0.46% to $13.7 million in 2025, then gained by 0.38% to $13.8 million in 2026.
• Per Business Quant, the three latest SNOA Assets Average figures stand at $13.8 million (Q1 2026), $13.7 million (Q4 2025), and $14.2 million (Q3 2025).